CLINICAL_TRIALS
trial_result
· 2020-07-16
Clinical Trial Update: Janagliflozin Treat T2DM Monotherapy [Phase 3]
Summary
A Phase 3 clinical trial update for janagliflozin as monotherapy in type 2 diabetes is in development, with the status currently unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sihuan Pharmaceutical Holdings Group Ltd. | Conditions: Diabetes Type 2 | Phase 3 | Status: UNKNOWN